Medtronic's earnings beat estimates as sales of diabetes and heart devices rise

Medtronic ’s stock rose about 2 percent in afternoon trading after the company reported earnings that beat analyst expectations. The medical-device giant’s adjusted profit in the fourth quarter reached $1.44 per share, 5 cents higher than Wall Street estimates. The company’s revenue climbed to $8.14 bi llion for the fourth quarter, up about 3 percent compared to the year-ago period. Medtronic reported revenue growth across most of its business lines, with sales in its diabetes business leaping…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news